Faculty, Staff and Student Publications
Language
English
Publication Date
3-1-2023
Journal
Nature
DOI
10.1038/s41586-023-05892-1
PMID
36894629
PMCID
PMC10033416
PubMedCentral® Posted Date
5-9-2023
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Recommended Citation
Amaria, Rodabe N; Postow, Michael; Burton, Elizabeth M; et al., "Author Correction: Neoadjuvant Relatlimab and Nivolumab in Resectable Melanoma" (2023). Faculty, Staff and Student Publications. 5253.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/5253
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Genetic Phenomena Commons, Medical Genetics Commons, Oncology Commons
Comments
This corrects the article "Neoadjuvant relatlimab and nivolumab in resectable melanoma" in volume 611 on page 155.